Brief: PharmaCyte Biotech Inc Releases More Positive Results From FDA-Required Biocompatibility Tests
21/09/2021 15:49
Sept 21 (Reuters) - PharmaCyte Biotech Inc PMCB.O :
* PHARMACYTE BIOTECH RELEASES MORE POSITIVE RESULTS FROM
FDA-REQUIRED BIOCOMPATIBILITY TESTS
* PHARMACYTE - FDA-REQUIRED TEST OF BIOCOMPATIBILITY OF ITS
CYPCAPS PRODUCT FOR PANCREATIC CANCER, SHOWED EMPTY CAPSULE
MATERIAL IS "NON-HEMOLYTIC"
Source text for Eikon: ID:nBw9G3qf6a
Further company coverage: PMCB.O
Recent news on Pharmacyte Biotech
See all newsBrief: Pharmacyte Biotech Inc - Increases Stake In Tnf Pharmaceuticals By $3 Million
Brief: PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease
Brief: Pharmacyte Biotech Acquires $5 Million Stake In Emerging Women’S Health Innovator Femasys
Brief: Femasys Inc. Secures Additional Financing With Strategic Investment From Investors Led By Pharmacyte Biotech
Brief: Pharmacyte Biotech Announces Final Results Of Tender Offer